Acute Hepatitis in Pediatrics
ConditionHepatitis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 17
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
About this trial
This study aims to investigate wich symptoms and blood test characteristics acute hepatitis manifests in pediatric age. The study will be conducted because acute hepatitis is not an easily and clearly recognized disease in children.
This study aims to better characterize this disease by describing the frequency of the different symptoms with which it can manifest and the changes it causes in blood tests. It also aims to assess the occurrence of any complications of pediatric acute hepatitis.
The study is observational, so it is limited to collecting data and analyzing the patient's clinical course without interfering with normal clinical practice.
Eligibility criteria
Qualifiers
Age between 0 and 17 years (extremes included).
Access to PSP and/or hospitalized (OBI or hospitalization)
Diagnosis of acute hepatitis
Disqualifiers
Refusal of the parent/guardian to participate in the study.
Mild hypertransaminasemia (<5 times the upper limit of normal) in a patient with known chronic liver dysfunction (e.g. liver cirrhosis).
Neonatal jaundice without hepatocyte involvement or signs of cholestasis (prevalence of indirect bilirubin with normal AST, ALT and GGT).
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov